Skip to content

Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia

Epidural Versus Continuous Wound Ropivacaine Infusion: Effect on Acute and Chronic Pain After Myomectomy or Total Abdominal Hysterectomy. A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01916473
Enrollment
80
Registered
2013-08-05
Start date
2010-04-30
Completion date
2012-11-30
Last updated
2013-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia

Keywords

Epidural analgesia, continuous wound infusion, ropivacaine, total abdominal hysterectomy

Brief summary

Study Hypothesis: The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques.

Detailed description

The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques, in patients undergoing myomectomy or hysterectomy.

Interventions

OTHEREpidural analgesia

Epidural analgesia is provided with ropvacaine 0.2% given 6 hourly

Continuous wound infusion via catheter

Sponsors

University of Athens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Patients ASA I-II scheduled for abdominal hysterectomy or myomectomy -

Exclusion criteria

Age older than 60 and younger than 25 years, body weight exceeding the 30% of the ideal, consumption of analgesics, sedatives, anxiolytics, antidepressants, calcium channel blockers, CNS disease or insulin dependent diabetes \-

Design outcomes

Primary

MeasureTime frame
Postoperative morphine consumption2 hours postoperatively

Secondary

MeasureTime frame
pain scores2 hours postoperatively

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026